Apoptosis. 2013 Nov;18(11):1348-1362. doi: 10.1007/s10495-013-0866-y.

中文速读

本研究使用L929细胞,通过HDAC抑制剂SAHA调控多条信号通路(NFκB、p38 MAPK、JNK、Akt/mTOR)保护细胞免受TNFα诱导的坏死性凋亡,但未使用Engreen产品。

体外(细胞)L929

本文使用:小核酸转染试剂Entranster™-R4000

查看产品详情(含全部 223 篇文献) →

The histone deacetylase inhibitor vorinostat prevents TNFα-induced necroptosis by regulating multiple signaling pathways.

Wang D1, Zhao M1, Chen G1, Cheng X1, Han X2, Lin S1, Zhang X1, Yu X3.

Author information

1Department of Stress Medicine, Beijing Institute of Basic Medical Sciences, Cognitive and Mental Health Research Center, #27 Taiping Road, Beijing, 100850, China.2Department of Biochemistry, China Medical University, Shenyang, China.3Department of Stress Medicine, Beijing Institute of Basic Medical Sciences, Cognitive and Mental Health Research Center, #27 Taiping Road, Beijing, 100850, China. yuxd@bmi.ac.cn.

Abstract

Histone deacetylase (HDAC) inhibitors are novel anticancer reagents that have recently been reported to have anti-inflammatory and neuroprotective effects; however, the mechanisms underlying their activities are largely undefined. The data from this study show that the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA) can protect L929 cells from TNFα-induced necroptosis. This effect involves multiple mechanisms, including the upregulation of cFLIPL expression, the enhanced activation of NFκB and p38 MAPK, and the inactivation of JNK. In addition, SAHA could initiate cell autophagy by inhibiting Akt and mTOR, which also play important roles in protecting cells from necroptosis. Because cell necroptosis is important for inflammation-related deterioration and neurodegenerative disease, our results indicate that preventing cell necrosis may be an important mechanism through which HDAC inhibitor compounds exert their anti-inflammatory or neuroprotective effects.

本文使用的产品

小核酸转染试剂Entranster™-R4000

已有 223 篇已发表文献

查看产品详情(含全部 223 篇文献) →

热线电话
  • 010-60535354
微信客服二维码 微信扫一扫,加微信客服
0
0
我的购物车
购物车是空的去下单